Stock PCLO PHARMACIELO LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News PharmaCielo Ltd.

Equities

PCLO

CA71716K1012

Market Closed - Toronto S.E.
Other stock markets
 20:58:13 26/04/2024 BST 		5-day change 1st Jan Change
0.15 CAD -3.23% Intraday chart for PharmaCielo Ltd. -16.67% -16.67%
04-10 PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding CI
01-04 Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors
NE
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding
CI
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil
NE
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo
NE
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products
CI
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products
NE
PharmaCielo Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
PharmaCielo Announces Q3 2023 Financial Results
NE
PharmaCielo Raises $3.3 Million Under Non-Brokered Private Placement
MT
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement
NE
PharmaCielo Ltd. announced that it has received CAD 4.78 million in funding
CI
PharmaCielo Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Pharmacielo Ltd. Appoints Marc Lustig as CEO
CI
Pharmacielo Ltd. Announces Board Changes
CI
PharmaCielo Ltd. announced that it expects to receive CAD 5 million in funding
CI
PharmaCielo Ltd. announced that it has received CAD 12.825 million in funding
CI
PharmaCielo Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
PharmaCielo Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
PharmaCielo Ltd. Auditor Raises 'Going Concern' Doubt
CI
PharmaCielo Receives Purchase Order for API from Brazilian Pharmaceutical Company Represents Third Customer in the Country
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PCLO Stock
  4. News PharmaCielo Ltd.